drugset / Trial / NCT00958503
Effect of Thiamphenicol on EAAT2 and Other Biomarkers From Nasal Biopsied Tissue
Phase 1
Completed
30 enrolled
Psyadon Pharma
SGS Life Sciences, a division of SGS Belgium NV · collab
RandomizedParallel-groupQuadruple-blindBasic science
Summary
The purpose of this study is to determine if two-weeks of dosing with thiamphenicol is safe and is able to change the levels of certain pre-specified biomarkers in nervous tissue taken from the nasal passages.
Timeline
- Start
- 2007-07
- Primary completion
- 2007-09
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Thiamphenicol | Small molecule | 750 mg | — |
| Comparator | Thiamphenicol | Small molecule | 1500 mg | — |
Indications
No indication recorded.